INSMED Inc Earnings Per Share Diluted

• INSMED Inc showed a decrease of -15.3% in Earnings Per Share Diluted from 2024 to 2025.
• This data is from INSMED Inc's annual report (Form 10-K), filed with the SEC on February 19, 2026.
• XBRL data for this metric is available from 2009 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2020: $0.64 (loss) per share | Q3 2020: $0.63 (loss) per share | Q1 2021: $0.89 (loss) per share | Q2 2021: $1.07 (loss) per share | Q3 2021: $0.96 (loss) per share | Q1 2022: $0.80 (loss) per share | Q2 2022: $0.80 (loss) per share | Q3 2022: $1.09 (loss) per share | Q1 2023: $1.17 (loss) per share | Q2 2023: $1.78 (loss) per share | Q3 2023: $1.11 (loss) per share | Q1 2024: $1.06 (loss) per share | Q2 2024: $1.94 (loss) per share | Q3 2024: $1.27 (loss) per share | Q1 2025: $1.42 (loss) per share | Q2 2025: $1.70 (loss) per share | Q3 2025: $1.75 (loss) per share.
• Over the full 10 years of available data (2009 to 2025), INSMED Inc's Earnings Per Share Diluted has declined by 169.0%.
• Historical annual values: Fiscal year 2025: $6.42 (loss) per share | Fiscal year 2024: $5.57 (loss) per share | Fiscal year 2023: $5.34 (loss) per share | Fiscal year 2022: $3.91 (loss) per share | Fiscal year 2021: $3.88 (loss) per share | Fiscal year 2020: $3.01 (loss) per share | Fiscal year 2019: $3.01 (loss) per share | Fiscal year 2011: $2.95 (loss) per share | Fiscal year 2010: $0.49 (loss) per share | Fiscal year 2009: $9.30 per share.
• Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: August 10, 2026